Patents by Inventor Florian Maria Wurm

Florian Maria Wurm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220112270
    Abstract: Embodiments of the present invention generally relate to recombinant alpha 1-antitrypsin (AAT) proteins, including variants of human AAT with individually introduced mutations, compositions containing such recombinant AAT proteins and carriers, expression plasmids or vectors and host cells that express such recombinant AAT proteins, methods of producing such recombinant AAT proteins, and methods of treating AAT deficiency-related diseases, disorders, and conditions or diseases, disorders, and conditions resulting in protease-induced tissue damage in a subject in need thereof with the recombinant AAT proteins and/or recombinant AAT protein compositions described here. The recombinant AAT proteins derived from mammalian host cells as produced by the methods described here may be produced in large quantities, without any animal components, i.e., highly pure, highly glycosylated, and may be advantageously used over plasma-derived AAT.
    Type: Application
    Filed: July 22, 2021
    Publication date: April 14, 2022
    Inventors: Maria João WURM, Florian Maria WURM, Sabina JANCIAUSKIENE, Jürg HAMACHER, Uz STAMMBERGER
  • Publication number: 20080145893
    Abstract: Recombinant proteins are of great commercial interest. Yet, most current production methods in mammalian cells involve the time- and labor-consuming step of creating stable cell lines. Production methods based on transient gene expression are advantageous in terms of speed and versatility, yet, thus far, those methods have not shown the specific productivity, batch yield and volumetric yield to be an economic alternative to stable cell lines. The inventors improved on the methodology of transient transfection and achieved commercially relevant yields in terms of specific productivity (exceeding 35 pg per cell per day), batch yield (exceeding 700 mg/l) and volumetric yield.
    Type: Application
    Filed: September 17, 2006
    Publication date: June 19, 2008
    Applicant: EXCELLEGENE SA
    Inventors: Markus Hildinger, Sarah Wulhfard, Gaurav Backliwal, David Hacker, Maria De Jesus, Florian Maria Wurm
  • Patent number: 6509174
    Abstract: Fluorescent protein expressing cells with very high fluorescence are described as well as a method to obtain such cells. The fluorescence of such cells can be as high as about 1000 times the auto-fluorescence of the respective host cell. Due to the high fluorescence, said cells are very suitable tools in the development, surveillance and/or optimization of production processes, for selection of culture media and process parameters and for the determination of cell growth and the detection, quantification and monitoring of biomass.
    Type: Grant
    Filed: June 16, 1998
    Date of Patent: January 21, 2003
    Assignee: Ecole Polytechnique Federal de Lausanne (EPFL)
    Inventors: Martin Jordan, Florian Maria Wurm
  • Publication number: 20020058334
    Abstract: Fluorescent protein expressing cells with very high fluorescence are described as well as a method to obtain such cells. The fluorescence of such cells can be as high as about 1000 times the auto-fluorescence of the respective host cell.
    Type: Application
    Filed: June 16, 1998
    Publication date: May 16, 2002
    Inventors: MARTIN JORDAN, FLORIAN MARIA WURM